Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
MitrAssist logo — company profile

MitrAssist

Founded 2009 Israel Israel 3 employees Series C Total: $181.00M Biotechnology, Health Care +1

General Information

Company Name MitrAssist
Founded Year 2009
Location Israel Israel +1
Employees 3
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series C
Social

Get notified when MitrAssist moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MitrAssist

MitrAssist is a biotechnology startup founded in 2009 and headquartered in Israel. Specializing in the field of cardiology, MitrAssist aims to provide a safe and minimally invasive solution for the treatment of patients suffering from mitral regurgitation (MR) who are ineligible for existing procedures. Their innovative minimally invasive mitral valve implant, designed to work in unison with the heart's own mitral valve, offers an improved, safe, and cost-effective treatment solution for MR patients through a "valve-in-valve" approach. The company recently secured a noteworthy $100.00M Series C investment on 26 September 2023, with participation from 6 Dimensions Capital, 合肥市产业投资控股(集团)有限公司, Centurium Capital, Haiheng Capital, and Anhui Huawen Capital Investment Management, offering hope to patients in need.

Taxonomy: cardiology, mitral regurgitation, minimally invasive, valve-in-valve approach, MR treatment, mitral valve implant, medical device, innovation, heart health, start-up, investor analysis

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 5
Investor Investor Investor
•••• •••• 		26 Sep 2023
Venture Round •••••• 5
Investor Investor Investor
•••• •••• 		03 Dec 2020
Venture Round •••••• - 11 Nov 2017
Angel Round •••••• - 01 Jul 2013

MitrAssist Alternatives & Competitors

MitrAssist vs
Valcare Medical
Valcare Medical Israel

Developing innovative transcatheter technologies for the treatment of mitral and tricuspid regurgita...

Convertible Note
33 employees
Health Care
MitrAssist vs
Tendyne Holdings Inc.
Tendyne Holdings Inc. United States

Pioneering minimally invasive solutions for mitral regurgitation treatment.

Series C
6 employees
Biotechnology, Medical Devices
MitrAssist vs
HighLife
HighLife France

Trans-septal Mitral Valve Replacement

Series C
84 employees
Health Care, Medical Devices

FAQ About MitrAssist

MitrAssist is a promising startup in the cardiology field. Our mission is to provide a safe and minimal invasive solution for the treatment of every patient suffering from mitral regurgitation (MR) who is ineligible for treatment provided by existing procedures. MitrAssist has developed a minimally...
MitrAssist was founded in 2009.
MitrAssist is headquartered in Israel.
MitrAssist operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
MitrAssist has approximately 3 employees.
MitrAssist has completed 4 funding rounds, raising a total of $181.00M. The latest funding stage is Series C.
Top alternatives and competitors to MitrAssist include Valcare Medical , Tendyne Holdings Inc., HighLife, HVR Cardio Oy, Hanyu Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MitrAssist and Valcare Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MitrAssist and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy